Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial (Q84539770)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 June 2010

Language	Label	Description	Also known as
English	Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial	scientific article published on 01 June 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

randomized experiment

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Julio Rosenstock

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Daniel L Lorber

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Luigi Gnudi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Campbell P Howard

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

David W Bilheimer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

P-C Chang

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Richard E Petrucci

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Anders H Boss

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Peter C Richardson

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

0 references

publication date

1 June 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

375

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

9733

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

2244-2253

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

randomized experiment

0 references

The natural history of type 2 diabetes. Implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal insulin treatment in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-year efficacy of complex insulin regimens in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Target for glycemic control: concentrating on glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A summary of the ADVANCE Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960632-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60632-0

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20609970%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84539770&oldid=1563408928"